Table 3.
Summary of clinical characteristics of the patients.
| Characteristics | CCRT | RT | ICT |
|---|---|---|---|
| Number of patients | 16 | 18 | 13 |
| Age [years] (median) | 49–75 (58) | 55–77 (63) | 46–80 (63) |
| Gender: male/female | 13/3 | 12/6 | 11/2 |
| Tumor localization | |||
| Oral cavity | 0 | 2 | 3 |
| Tonsil | 2 | 3 | 3 |
| Pharynx | 7 | 1 | 7 |
| Larynx | 7 | 12 | 0 |
| TNM staging | |||
| T1 | 0 | 1 | 0 |
| T2 | 4 | 11 | 1 |
| T3 | 7 | 6 | 6 |
| T4 | 5 | 0 | 6 |
| N0 | 6 | 16 | 1 |
| N1 | 2 | 1 | 1 |
| N2 | 8 | 1 | 7 |
| N3 | 0 | 0 | 4 |
| Radiotherapy | |||
| Total dose [Gy] (median) | 70 | 50-72 (72) | - |
| 7x1,8Gy/week | 0 | 10 | - |
| 5x2Gy/week | 16 | 2 | - |
| 5x2,2Gy/week | 0 | 4 | - |
| 5x2,5Gy/week | 0 | 2 | - |
| Chemotherapy | |||
| Cisplatin (100 mg/m2) | 16 | - | 5 |
| Cisplatin (100 mg/m2) + 5-fluorouracil (800 mg/m2) | 0 | - | 8 |